The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus

Surgery

Volumn 141, Issue 5, 2007, Pages 570-580

  Matsuyama, Jin ^a   Doki, Yuichiro ^a   Yasuda, Takushi ^a   Miyata, Hiroshi ^a   Fujiwara, Yoshiyuki ^a   Takiguchi, Shuji ^a   Yamasaki, Makoto ^a   Makari, Yoichi ^a   Matsuura, Nariaki ^b   Mano, Masayuki ^c   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Tottori University   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOKERATIN; DOXORUBICIN; EOSIN; FLUOROURACIL; HEMATOXYLIN; PLATINUM;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; ERADICATION THERAPY; ESOPHAGUS CANCER; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THORAX WALL; TREATMENT RESPONSE;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; PROGNOSIS;

EID: 34247229570     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.11.007     Document Type: Article

References (26)

1. Urschel J.D., and Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185 (2003) 538-543
2. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
3. Stahl M., Stuschke M., Lehmann N., Meyer H.J., Walz M.K., Seeber S., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
4. Group MRCOCW. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 (2002) 1727-1733
5. DeVita V., Hellmann S., and Rosenberg S. Cancer principles and practice of oncology. 7th ed. (2005), Lippincott Williams and Wilkins, Philadelphia, (PA)
6. Bonavina L., Soligo D., Quirici N., Bossolasco P., Cesana B., Lembertenghi Deliliers G., et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 129 (2001) 15-22
7. Kijima F., Natsugoe S., Takao S., Aridome K., Baba M., Yoshifumi M., et al. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 58 (2000) 38-44
8. Luketich J.D., Kassis E.S., Shriver S.P., Nguyen N.T., Schauer P.R., Weigel T.L., et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 66 (1998) 1715-1718
9. Glickman J.N., Torres C., Wang H.H., Turner J.R., Shahsafaei A., Richards W.G., et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 85 (1999) 769-778
10. Komukai S., Nishimaki T., Watanabe H., Ajioka Y., Suzuki T., and Hatakeyama K. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery 127 (2000) 40-46
11. Sato F., Shimada Y., Li Z., Watanabe G., Maeda M., and Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 88 (2001) 426-432
12. Doki Y., Ishikawa O., Takachi k., Miyashiro I., Sasaki Y., Ohigashi H., et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 29 (2005) 700-707
13. Doki Y., Ishikawa O., Mano M., Hiratsuka M., Sasaki Y., Kameyama M., et al. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res 107 (2002) 75-81
14. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. 6th ed. (2002), John Wiley and Sons, Inc, New York
15. Yasuda T., Kabuto T., Ishiguro S., Nakano H., Nakamori S., Ohigashi H., et al. Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus. Gan To Kagaku Ryoho 22 (1995) 1538-1541
16. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al., European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
17. Doki Y., Ishikawa O., Kabuto T., Hiratsuka M., Sasaki Y., Ohigashi H., et al. Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach. Surgery 133 (2003) 479-485
18. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
19. Natsugoe S., Mueller J., Stein H.J., Feith M., Hofler H., and Siewert J.R. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer 83 (1998) 858-866
20. Hannigan G., Troussard A.A., and Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5 (2005) 51-63
21. Lee J.W., and Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 17 (2004) 188-202
22. Thompson J.E., and Thompson C.B. Putting the rap on Akt. J Clin Oncol 22 (2004) 4217-4226
23. Arlt A., and Schafer H. NFkappaB-dependent chemoresistance in solid tumors. Int J Clin Pharmacol Ther 40 (2002) 336-347
24. Durand R.E. Intermittent blood flow in solid tumours-an under-appreciated source of 'drug resistance'. Cancer Metastasis Rev 20 (2001) 57-61
25. Urschel J.D., Ashiku S., Thurer R., and Sellke F.W. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer-a review. Dis Esophagus 16 (2003) 60-65
26. Ohtsu A. Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol 9 (2004) 444-450